NSFL1C Antibody - BSA Free

Immunohistochemistry-Paraffin: NSFL1C Antibody [NBP2-13677]

Immunohistochemistry-Paraffin: NSFL1C Antibody [NBP2-13677] - Staining of human testis.

Immunohistochemistry-Paraffin: NSFL1C Antibody [NBP2-13677]

Immunohistochemistry-Paraffin: NSFL1C Antibody [NBP2-13677] - Staining of human kidney.

Immunohistochemistry-Paraffin: NSFL1C Antibody [NBP2-13677]

Immunohistochemistry-Paraffin: NSFL1C Antibody [NBP2-13677] - Staining of human cerebral cortex.

Immunohistochemistry-Paraffin: NSFL1C Antibody [NBP2-13677]

Immunohistochemistry-Paraffin: NSFL1C Antibody [NBP2-13677] - Staining of human lymph node.

Western Blot: NSFL1C Antibody [NBP2-13677] -

Western Blot: NSFL1C Antibody [NBP2-13677] - Analysis in human cell line A-549.

Western Blot: NSFL1C Antibody [NBP2-13677] -

Western Blot: NSFL1C Antibody [NBP2-13677] - PINK1 phosphorylates the activation loop of PKA. A, IP products of HEK293 cell lysates expressing GFP or PINK1-GFP reveal that PINK1 pulls down the PKA holoenzyme (PKAcat & PKAreg) in addition to VCP & p47. B, IP products of HEK293 lysates expressing PINK1-GFP, GFP or GFP-VCP reveal that either PINK1 or VCP pull down p47, but only PINK1 pulls down PKAreg. C, IP products of HEK293 lystates expressing Vector or MYC-p47 reveals that p47 does not interact w/ PKAcat or PKAreg. D, 2-D analysis of endogenous PKA subunits in control (M14) & PINK1-3xFlag (#24) stable SH-SY5Y lines reveal an acidic shift of PKAcat (arrow), but not PKAreg, in PINK1-overexpressing cells. E, Structural model for the MD-equilibrated (100 ns) complex between hPINK1 (pink) & PKAcat (green). PKA-T197 (cyan balls) & PINK1-D362 (orange balls) are shown in relation to PINK1-bound ATP w/ two Mg2+ (purple). Red, tan, white, cyan, & blue represent O, P, H, C, & N atoms, respectively, of ATP. F, Immunoblot analysis of HEK293 cells transfected w/ GFP or PINK1-GFP reveals that PINK1-GFP increases PKAcat phosphorylation at T197, but has no effect on PKAreg phosphorylation at S99 (mean ± SD, three independent experiments, p = 0.014). G, Recombinant PKAcat purified from E. coli, which is already phosphorylated at T197, dephosphorylated by incubation w/ lambda phosphatase (PP) at 30°C × 1 h. Successful dephosphorylation verified by immunoblot. H, In vitro kinase assay of human GST-PINK1 w/ dephosphorylated recombinant PKAcat in the presence or absence of the PKA inhibitor H89 reveals that hPINK1 phosphorylates PKA at T197. I, In vitro kinase assay of GST-TcPINK1 w/ dephosphorylated recombinant PKAcat reveals that TcPINK1 is also capable of directly phosphorylating PKAcat. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/30783609), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Western Blot: NSFL1C Antibody [NBP2-13677] -

Western Blot: NSFL1C Antibody [NBP2-13677] - PINK1 phosphorylates the activation loop of PKA. A, IP products of HEK293 cell lysates expressing GFP or PINK1-GFP reveal that PINK1 pulls down the PKA holoenzyme (PKAcat & PKAreg) in addition to VCP & p47. B, IP products of HEK293 lysates expressing PINK1-GFP, GFP or GFP-VCP reveal that either PINK1 or VCP pull down p47, but only PINK1 pulls down PKAreg. C, IP products of HEK293 lystates expressing Vector or MYC-p47 reveals that p47 does not interact w/ PKAcat or PKAreg. D, 2-D analysis of endogenous PKA subunits in control (M14) & PINK1-3xFlag (#24) stable SH-SY5Y lines reveal an acidic shift of PKAcat (arrow), but not PKAreg, in PINK1-overexpressing cells. E, Structural model for the MD-equilibrated (100 ns) complex between hPINK1 (pink) & PKAcat (green). PKA-T197 (cyan balls) & PINK1-D362 (orange balls) are shown in relation to PINK1-bound ATP w/ two Mg2+ (purple). Red, tan, white, cyan, & blue represent O, P, H, C, & N atoms, respectively, of ATP. F, Immunoblot analysis of HEK293 cells transfected w/ GFP or PINK1-GFP reveals that PINK1-GFP increases PKAcat phosphorylation at T197, but has no effect on PKAreg phosphorylation at S99 (mean ± SD, three independent experiments, p = 0.014). G, Recombinant PKAcat purified from E. coli, which is already phosphorylated at T197, dephosphorylated by incubation w/ lambda phosphatase (PP) at 30°C × 1 h. Successful dephosphorylation verified by immunoblot. H, In vitro kinase assay of human GST-PINK1 w/ dephosphorylated recombinant PKAcat in the presence or absence of the PKA inhibitor H89 reveals that hPINK1 phosphorylates PKA at T197. I, In vitro kinase assay of GST-TcPINK1 w/ dephosphorylated recombinant PKAcat reveals that TcPINK1 is also capable of directly phosphorylating PKAcat. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/30783609), licensed under a CC-BY license. Not internally tested by Novus Biologicals.